158 related articles for article (PubMed ID: 8884352)
1. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.
Jensen ML; Kiaer H; Melsen F
Histopathology; 1996 Sep; 29(3):241-5. PubMed ID: 8884352
[TBL] [Abstract][Full Text] [Related]
2. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
Dalal P; Shousha S
Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin and beta-catenin expression in breast medullary carcinomas.
Charpin C; Bonnier P; Garcia S; Andrac L; Crebassa B; Dorel M; Lavaut MN; Allasia C
Int J Oncol; 1999 Aug; 15(2):285-92. PubMed ID: 10402239
[TBL] [Abstract][Full Text] [Related]
4. Medullary carcinoma of the breast: a tumour lacking keratin 19.
Larsimont D; Lespagnard L; Degeyter M; Heimann R
Histopathology; 1994 Jun; 24(6):549-52. PubMed ID: 7520414
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
J Clin Pathol; 1993 Nov; 46(11):1009-10. PubMed ID: 8254086
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of steroid hormone receptors with respect to tumor cellularity.
Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
[TBL] [Abstract][Full Text] [Related]
7. Localization of metallothionein in breast carcinomas. An immunohistochemical study.
Fresno M; Wu W; Rodriguez JM; Nadji M
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):215-9. PubMed ID: 8236816
[TBL] [Abstract][Full Text] [Related]
8. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.
Kajiwara M; Toyoshima S; Yao T; Tanaka M; Tsuneyoshi M
J Surg Oncol; 1999 Apr; 70(4):209-16. PubMed ID: 10219015
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
11. Correlation between oestrogen receptor protein expression in infiltrating ductal carcinoma of the breast by immunohistochemistry and cytosol measurements.
Looi LM; Yap SF; Cheah PL
Ann Acad Med Singap; 1997 Nov; 26(6):750-3. PubMed ID: 9522973
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer: comparison between biochemical and immunohistochemical determination of estrogen receptors].
Roa JC; Baeza R; Romeo E; Andrade L; Foradori A; González S
Rev Med Chil; 1996 Mar; 124(3):307-12. PubMed ID: 9008942
[TBL] [Abstract][Full Text] [Related]
13. 1D5 and 6F11: An immunohistochemical comparison of two monoclonal antibodies for the evaluation of estrogen receptor status in primary breast carcinoma.
Kaplan PA; Frazier SR; Loy TS; Diaz-Arias AA; Bradley K; Bickel JT
Am J Clin Pathol; 2005 Feb; 123(2):276-80. PubMed ID: 15842054
[TBL] [Abstract][Full Text] [Related]
14. The cytokeratin profile of medullary carcinoma of the breast.
Tot T
Histopathology; 2000 Aug; 37(2):175-81. PubMed ID: 10931242
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
16. Prognostic comparison of three classifications for medullary carcinomas of the breast.
Jensen ML; Kiaer H; Andersen J; Jensen V; Melsen F
Histopathology; 1997 Jun; 30(6):523-32. PubMed ID: 9205856
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of p53 protein expression in breast carcinomas.
Hurlimann J
Pathol Res Pract; 1993 Nov; 189(9):996-1003. PubMed ID: 8302733
[TBL] [Abstract][Full Text] [Related]
18. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
Wendroth SM; Mentrikoski MJ; Wick MR
Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
[TBL] [Abstract][Full Text] [Related]
19. Profile of breast cancer in a group of women in a developing country in South Asia: is there a difference?
Lokuhetty MD; Ranaweera GG; Wijeratne MD; Wickramasinghe KH; Sheriffdeen AH
World J Surg; 2009 Mar; 33(3):455-9. PubMed ID: 19123026
[TBL] [Abstract][Full Text] [Related]
20. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas.
Malzahn K; Mitze M; Thoenes M; Moll R
Virchows Arch; 1998 Aug; 433(2):119-29. PubMed ID: 9737789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
